Josh Friedman
Senior Staff Writer at HemOnc Today
Senior staff writer @HemOncToday; Former sports reporter for @cpsj @thedailyjournal; @SyracuseU grad; The Dude abides.
Articles
-
5 days ago |
healio.com | Josh Friedman
Key takeaways: First-line anlotinib plus chemotherapy had noninferior PFS to bevacizumab plus chemotherapy for certain metastatic colorectal cancer. Anlotinib had higher toxicities and may not provide enough benefits. CHICAGO — Anlotinib plus chemotherapy demonstrated similar efficacy as bevacizumab plus chemotherapy for certain patients with unresectable metastatic colorectal cancer, according to findings presented at ASCO Annual Meeting.
-
6 days ago |
healio.com | Josh Friedman
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.
-
6 days ago |
healio.com | Josh Friedman
Key takeaways:Detection of ESR1 mutations with ctDNA before progression of certain advanced breast cancers may allow for early intervention. Switching to camizestrant significantly improved outcomes after detection. CHICAGO — Testing for ESR1 mutations during first-line treatment of ER-positive, HER2-negative advanced breast cancer could allow for early intervention to improve survival, according to results of a randomized phase 3 trial.
-
6 days ago |
healio.com | Josh Friedman
Key takeaways: The addition of anlotinib to standard of care for newly diagnosed glioblastoma significantly improved PFS in a randomized phased 2 trial. However, OS did not differ between anlotinib and placebo arms. CHICAGO — Adding anlotinib to standard temozolomide-based chemoradiotherapy significantly extended PFS for newly diagnosed glioblastoma in a randomized phase 2 trial, according to findings presented at ASCO Annual Meeting.
-
6 days ago |
healio.com | Josh Friedman
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 9K
- Tweets
- 59K
- DMs Open
- Yes
Won a free @Topps heritage pack on @fanaticslive in a giveaway from @EastWestBreaks - Pretty cool hit. https://t.co/1hHfpCHSEP
RT @PhilsTailgate: Guy Gaudreau, the father of Johnny and Matthew Gaudreau, will throw out the ceremonial first pitch Tuesday night at Citi…
Where have these been all my life? @reeses https://t.co/H1H5AMzoCC